Dergi makalesi Açık Erişim
Yaman, Selma; Cukadar, Nursima; Baran, Furkan; Uyanik, Fatih Burak; Kilinc, Metin; Mert, Tufan
{ "@context": "https://schema.org/", "@id": 67583, "@type": "ScholarlyArticle", "creator": [ { "@type": "Person", "affiliation": "Kahramanmaras Sutcu Imam Univ, Tip Fak, Biyofiz Anabilim Dali, Kahramanmaras, Turkey", "name": "Yaman, Selma" }, { "@type": "Person", "affiliation": "Kahramanmaras Sutcu Imam Univ, Tip Fak, Biyofiz Anabilim Dali, Kahramanmaras, Turkey", "name": "Cukadar, Nursima" }, { "@type": "Person", "affiliation": "Kahramanmaras Sutcu Imam Univ, Tip Fak, Biyofiz Anabilim Dali, Kahramanmaras, Turkey", "name": "Baran, Furkan" }, { "@type": "Person", "affiliation": "Kahramanmaras Sutcu Imam Univ, Tip Fak, Biyofiz Anabilim Dali, Kahramanmaras, Turkey", "name": "Uyanik, Fatih Burak" }, { "@type": "Person", "affiliation": "Tibbi Biyokimya Anabilim Dali, Kahramanmaras, Turkey", "name": "Kilinc, Metin" }, { "@type": "Person", "affiliation": "Kahramanmaras Sutcu Imam Univ, Tip Fak, Biyofiz Anabilim Dali, Kahramanmaras, Turkey", "name": "Mert, Tufan" } ], "datePublished": "2019-01-01", "description": "Purpose: This study aimed to investigate the possible antinociceptive, anti-inflammatory and anti-edema effects of systemic (intaperitoneal) and local (intraplantar) bevacizumab in the experimental inflammation model (introduced with Carrageenan).", "headline": "Antiangiogenic effect of bevacizumab in monoclonal antibodies in experimental inflammatory pain model", "identifier": 67583, "image": "https://aperta.ulakbim.gov.tr/static/img/logo/aperta_logo_with_icon.svg", "license": "http://www.opendefinition.org/licenses/cc-by", "name": "Antiangiogenic effect of bevacizumab in monoclonal antibodies in experimental inflammatory pain model", "url": "https://aperta.ulakbim.gov.tr/record/67583" }
Görüntülenme | 38 |
İndirme | 12 |
Veri hacmi | 2.7 kB |
Tekil görüntülenme | 31 |
Tekil indirme | 11 |